Modulators of CFTR

Details for Australian Patent Application No. 2008251504 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Miller, Mark; Zhou, Jinglan; Bear, Brian; Hadida Ruah, Sara; Grootenhuis, Peter D.J.; McCartney, Jason

Agent Baldwins

Pub. Number AU-A-2008251504

PCT Pub. Number WO2008/141119

Priority 60/928,334 09.05.07 US

Filing date 9 May 2008

Wipo publication date 20 November 2008

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/444 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/141119 Priority application(s): WO2008/141119

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008251506-Method of monitoring and inhibiting scale deposition in pulp mill evaporators and concentrators

2008251499-Use of HDAC inhibitors for the treatment of melanoma